The French National Medicines Safety Agency (ANSM) has officially stated that flowers will not be incorporated into its forthcoming comprehensive medical cannabis framework. Although somewhat anticipated, the sudden decision and the ANSM’s failure to propose any feasible alternatives for patients reliant on cannabis flower have triggered widespread outrage.
The Trump administration is preparing to move cannabis from Schedule I to Schedule III of…
Based on the ruling, products that are legal federally as well as at the state…
The drug’s history of healing and experimentation stretches from ancient China to American counterculture —…
The new partnership will spotlight the stories of people still behind bars for cannabis, support…
Colombia is moving forward with a controversial plan to euthanize dozens of invasive hippos descended…
Imported hashish sustained mountain economies for centuries—until modern legalization and market economics erased it almost…